Cases & Deals

Wuyi International issues HK$801 million of Equity Shares in IPO in Hong Kong and concurrent Rule 144A and Regulation S offerings

Clients Wuyi International Pharmaceutical Company Limited

Jones Day advised Wuyi International Pharmaceutical Company Limited in connection with HK$801 million of Equity Shares in an initial public offering in Hong Kong and concurrent Rule 144A and Regulation S offerings, underwritten by Credit Suisse, UBS Investment Bank, and Sun Hung Kai International Limited.

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.